240 related articles for article (PubMed ID: 23673309)
21. Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease.
Liu X; Hao W; Qin Y; Decker Y; Wang X; Burkart M; Schötz K; Menger MD; Fassbender K; Liu Y
Brain Behav Immun; 2015 May; 46():121-31. PubMed ID: 25637484
[TBL] [Abstract][Full Text] [Related]
22. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model.
Schmöle AC; Lundt R; Ternes S; Albayram Ö; Ulas T; Schultze JL; Bano D; Nicotera P; Alferink J; Zimmer A
Neurobiol Aging; 2015 Feb; 36(2):710-9. PubMed ID: 25443294
[TBL] [Abstract][Full Text] [Related]
24. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease.
Yang W; Chauhan A; Mehta S; Mehta P; Gu F; Chauhan V
Life Sci; 2014 Mar; 99(1-2):31-6. PubMed ID: 24486299
[TBL] [Abstract][Full Text] [Related]
25. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.
Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL
Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
[TBL] [Abstract][Full Text] [Related]
27. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
Martin E; Boucher C; Fontaine B; Delarasse C
Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
[TBL] [Abstract][Full Text] [Related]
28. p38α-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic Alzheimer's disease mice.
Luo Q; Schnöder L; Hao W; Litzenburger K; Decker Y; Tomic I; Menger MD; Liu Y; Fassbender K
Aging Cell; 2022 Aug; 21(8):e13679. PubMed ID: 35909315
[TBL] [Abstract][Full Text] [Related]
29. Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice.
McManus RM; Higgins SC; Mills KH; Lynch MA
Neurobiol Aging; 2014 Jan; 35(1):109-21. PubMed ID: 23993702
[TBL] [Abstract][Full Text] [Related]
30. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
McGeer PL; McGeer EG
Acta Neuropathol; 2013 Oct; 126(4):479-97. PubMed ID: 24052108
[TBL] [Abstract][Full Text] [Related]
31. Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.
Ma C; Hunt JB; Kovalenko A; Liang H; Selenica MB; Orr MB; Zhang B; Gensel JC; Feola DJ; Gordon MN; Morgan D; Bickford PC; Lee DC
Front Immunol; 2021; 12():628156. PubMed ID: 34046031
[TBL] [Abstract][Full Text] [Related]
32. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice.
Ma T; Gong K; Ao Q; Yan Y; Song B; Huang H; Zhang X; Gong Y
Cell Transplant; 2013; 22 Suppl 1():S113-26. PubMed ID: 24070198
[TBL] [Abstract][Full Text] [Related]
33. Modulation of Alzheimer's disease brain pathology in mice by gut bacterial depletion: the role of IL-17a.
Hao W; Luo Q; Tomic I; Quan W; Hartmann T; Menger MD; Fassbender K; Liu Y
Gut Microbes; 2024; 16(1):2363014. PubMed ID: 38904096
[TBL] [Abstract][Full Text] [Related]
34. Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
Ryman D; Gao Y; Lamb BT
Neurobiol Aging; 2008 Aug; 29(8):1190-8. PubMed ID: 17400334
[TBL] [Abstract][Full Text] [Related]
35. GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease.
Audoy-Rémus J; Bozoyan L; Dumas A; Filali M; Lecours C; Lacroix S; Rivest S; Tremblay ME; Vallières L
Brain Behav Immun; 2015 May; 46():112-20. PubMed ID: 25637481
[TBL] [Abstract][Full Text] [Related]
36. Sustained Alzheimer's amyloid pathology in myeloid differentiation protein-88-deficient APPswe/PS1 mice.
Goll Y; Bekenstein U; Barbash S; Greenberg DS; Zangen R; Shoham S; Soreq H
Neurodegener Dis; 2014; 13(2-3):58-60. PubMed ID: 24192711
[TBL] [Abstract][Full Text] [Related]
37. IKKβ deficiency in myeloid cells ameliorates Alzheimer's disease-related symptoms and pathology.
Liu Y; Liu X; Hao W; Decker Y; Schomburg R; Fülöp L; Pasparakis M; Menger MD; Fassbender K
J Neurosci; 2014 Sep; 34(39):12982-99. PubMed ID: 25253847
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Schetters S; Orre M; Hol EM
Biochim Biophys Acta; 2016 Oct; 1862(10):1847-60. PubMed ID: 27425031
[TBL] [Abstract][Full Text] [Related]
39. The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
Pimentel LS; Allard S; Do Carmo S; Weinreb O; Danik M; Hanzel CE; Youdim MB; Cuello AC
J Alzheimers Dis; 2015; 47(2):373-83. PubMed ID: 26401560
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-26b is upregulated in a double transgenic mouse model of Alzheimer's disease and promotes the expression of amyloid-β by targeting insulin-like growth factor 1.
Liu H; Chu W; Gong L; Gao X; Wang W
Mol Med Rep; 2016 Mar; 13(3):2809-14. PubMed ID: 26847596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
